Q&A with K. Kimberly McCleary President & CEO
The CFIDS Association of America
A 2011 article in The Scientist alerted Suzanne to companies applying informatics to drug repurposing. One of them, Biovista, applied to our 2011 funding opportunity and its proposal to identify non-obvious drug therapies for CFS scored well for scientific and strategic merit. This project is now part of our Research Institute Without Walls and will utilize data from the SolveCFS BioBank in addition to its proprietary COSS platform to develop a target list of evidence-based drug repurposing candidates.